mp tscpc (Wolters Kluwer Health)
Structured Review
Mp Tscpc, supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mp-tscpc/mp+tscpc/10__1097_slash_ijg__0000000000002710-139-11-17
Average 86 stars, based on 1 article reviews
Images
Related Articles
Medications:Article Title: Cyclophotocoagulation as a Minimally Invasive Treatment Option for Glaucoma Article Snippet: Compared with Article Title: Efficacy of Micropulse Laser Cyclophotocoagulation Therapy in Primary Angle Closure Glaucoma Article Snippet: Patients and Methods: Thirty-three phakic PACG eyes with patent laser peripheral iridotomy and IOP uncontrolled on maximum tolerable antiglaucomamedications (AGMs), scheduled for trabeculectomy, were given a trial ofMP-TSCPC (810 nm laser, 2000 mw power for 180 seconds, 360 degrees).. The primary outcome measure was a success at 1 year with IOP ≤18 mmHg and ≤15 mmHg with (qualified success) or without (absolute success) AGMs after a single session of MP laser.. Secondary outcome measures were changes in pupillary diameter, visual acuity, central macular thickness, and subjective pain perception. Article Title: Outcomes of Micropulse Transscleral Cyclophotocoagulation in Uncontrolled Glaucoma Patients Article Snippet: Published by |
